2021-01-11,Lilly Rockets On Alzheimer's News  And 3 Other Highlights From Key Health Care Meeting
2021-01-10,"Alnylam Launches ""Alnylam P5x25"" Strategy for Planned Transition to a Top Five Biotech in Market Capitalization Over Next Five Years"
2021-01-08,Alnylam (ALNY) Posts Positive Top-Line Data From Vutrisiran Study
2021-01-07,Alnylam Reports Positive Topline Results from HELIOS-A Phase 3 Study of Vutrisiran in Patients with hATTR Amyloidosis with Polyneuropathy
2021-01-04,Alnylam to Webcast Presentation at 39th Annual J.P. Morgan Healthcare Conference
2020-12-21,Update: Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Gained 52% In The Last Five Years
2020-12-21,"Alnylam Appoints Tolga Tanguler Chief Commercial Officer and Also Announces New CEMEA, Medical Affairs, and Compliance Leaders"
2020-12-20,Is ALNY A Good Stock To Buy Now According To Hedge Funds?
2020-12-17,12 Best Large Biotech Stocks to Buy Now
2020-12-15,Alnylam Announces 2021 Product and Pipeline Goals and Provides Program Updates at R&D Day
2020-12-14,Blackstones $3.45 Billion Deal For Lab Space Shows Boom in Life Sciences
2020-12-08,Alnylam to Webcast Virtual R&D Day
2020-12-07,Alnylam Issues 2nd Annual Patient Access Philosophy Report Highlighting Broad Access to the Companys Approved Therapies
2020-12-05,Why Is Alnylam (ALNY) Down 6% Since Last Earnings Report?
2020-12-04,Is The FDA Still Approving Drugs During the Pandemic?
2020-12-04,Alnylam (ALNY) Ends Enrollment in Advanced Hyperoxaluria Study
2020-12-03,PANTHERx Rare® Pharmacy Chosen as Partner by Alnylam Pharmaceuticals for OXLUMO (lumasiran) for the Treatment of Primary Hyperoxaluria Type 1 (PH1) to Lower Urinary Oxalate Levels
2020-12-03,Orsini Specialty Pharmacy Expands Partnership With Alnylam® Pharmaceuticals As A Limited Distribution Partner For OXLUMO (lumasiran)
2020-12-03,"Alnylam Completes Enrollment in ILLUMINATE-C Phase 3 Study of Lumasiran, an RNAi Therapeutic, for the Treatment of Advanced Primary Hyperoxaluria Type 1"
2020-11-30,2 Biotech Funds Poised for a Healthy Breakout
2020-11-30,Reasons Alnylam Is a Top Biotech Stock to Buy Right Now
2020-11-30,3 Reasons Alnylam Is a Top Biotech Stock to Buy Right Now
2020-11-25,"Biotech Stock Roundup: REGN's Cocktail Gets EUA, GILD & AMGN Provide Updates & More"
2020-11-25,Alnylam (ALNY) Gets FDA Nod for Oxlumo to Treat Renal Disease
2020-11-25,Alnylam to Webcast Presentation at 43rd Nasdaq Virtual Investor Conference
2020-11-24,"The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia"
2020-11-24,Alnylam Announces Innovative Value-Based Agreement Framework for OXLUMO (lumasiran) to Accelerate Access for Patients with Primary Hyperoxaluria Type 1 and Deliver Ultra-Rare Orphan Disease Pricing Solutions to U.S. Payers
2020-11-24,"Alnylam Announces U.S. Food and Drug Administration (FDA) Approval of OXLUMO (lumasiran), the First and Only Treatment Approved for Primary Hyperoxaluria Type 1 to Lower Urinary Oxalate Levels in Pediatric and Adult Patients"
2020-11-20,Alnylam (ALNY) Gets EU Nod for Oxlumo to Treat Renal Disease
2020-11-19,Alnylam Receives Approval for OXLUMO (lumasiran) in the European Union for the Treatment of Primary Hyperoxaluria Type 1 in All Age Groups
2020-11-13,"Alnylam Reports Positive Interim Results from Ongoing Phase 1 Study of ALN-AGT, an Investigational RNAi Therapeutic for the Treatment of Hypertension"
2020-11-07,"Earnings Update: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts"
2020-11-06,"Alnylam's (ALNY) Q3 Loss Wider Than Expected, Revenues Beat"
2020-11-05,Alnylam Pharmaceuticals Inc (ALNY) Q3 2020 Earnings Call Transcript
2020-11-05,Alnylam Pharmaceuticals Reports Third Quarter 2020 Financial Results and Highlights Recent Period Activity
2020-11-04,Is a Surprise Coming for Alnylam (ALNY) This Earnings Season?
2020-11-03,"Were These Hedge Funds Wrong About Alnylam Pharmaceuticals, Inc. (ALNY)?"
2020-11-02,Alnylam to Webcast Presentations at Upcoming November Investor Conferences
2020-10-31,"Kaskela Law LLC Announces Stockholder Investigation of Alnylam Pharmaceuticals, Inc. - ALNY"
2020-10-30,"Alnylam Wins Prestigious Prix Galien Award for Best Biotechnology Product with First-Ever Approved RNAi Therapeutic, ONPATTRO® (patisiran)"
2020-10-29,Alnylam Named a Top Biopharma Employer by Science Magazine
2020-10-29,Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
2020-10-22,Alnylam to Webcast Conference Call Discussing Third Quarter 2020 Financial Results
2020-10-22,Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy?
2020-10-22,Alnylam Presents Positive Results from ILLUMINATE-B Phase 3 Study in Pediatric Patients with Primary Hyperoxaluria Type 1 at the American Society of Nephrology Kidney Week
2020-10-19,Is Ionis Pharmaceuticals a Buy?
2020-10-19,Alnylam (ALNY) Gets Positive CHMP Opinion for Lumasiran
2020-10-18,Can Either of These Little-Known Biotechs Find New Life Fighting Coronavirus?
2020-10-16,Alnylam Receives Positive CHMP Opinion for OXLUMO (lumasiran) for the Treatment of Primary Hyperoxaluria Type 1 in All Age Groups
2020-10-15,Vertex Tumbles As It Stops Testing On Protein Deficiency Treatment
2020-10-11,"When Will Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Turn A Profit?"
2020-10-01,Alnylam Releases Positive Top-Line Rare Disease Lumasiran Data
2020-09-30,Alnylam Pharmaceuticals Posts Positive Results For Its Treatment For Rare Disease
2020-09-30,Alnylam Reports Positive Topline Results from ILLUMINATE-B Phase 3 Study of Lumasiran for the Treatment of Primary Hyperoxaluria Type 1 in Children Under the Age of Six
2020-09-28,Alnylam to Webcast Presentation at Chardan Virtual 4th Annual Genetic Medicines Conference
2020-09-16,Arrowhead Pharma Reveals Positive Data On Drug To Treat Liver Disease; ARWR Stock Jumps
2020-09-09,"Hedge Funds Have Never Been This Bullish On Alnylam Pharmaceuticals, Inc. (ALNY)"
2020-09-09,3 Healthcare Stocks I Can't Wait to Buy When the Stock Market Tanks Again
2020-09-05,Why Is Alnylam (ALNY) Down 14.8% Since Last Earnings Report?
2020-09-04,"Analyst Report: Alnylam Pharmaceuticals, Inc."
2020-09-03,Alnylam Highlights Prospects for Building an Industry-Leading ATTR Amyloidosis Franchise at RNAi Roundtable
2020-09-02,Alnylam to Webcast Presentations at Upcoming September Investor Conferences
2020-08-27,Alnylam's Share Price Rises YTD on Pipeline Developments
2020-08-27,"Here's What We Learned About The CEO Pay At Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)"
2020-08-17,Blackstone and Alnylam Close $150 Million R&D Financing to Advance RNAi Therapeutics for Cardiovascular Disease
2020-08-07,"Alnylam (ALNY) Beats on Q2 Earnings, Narrows Sales Guidance"
2020-08-06,"Alnylam Pharmaceuticals (ALNY) Reports Q2 Loss, Tops Revenue Estimates"
2020-08-06,Alnylam Pharmaceuticals Reports Second Quarter 2020 Financial Results and Highlights Recent Period Activity
2020-08-06,"Alnylam Announces Planned Transition of Barry Greene, President"
2020-08-03,"Alnylam Submits CTA Application for ALN-HSD, an Investigational RNAi Therapeutic for the Treatment of Nonalcoholic Steatohepatitis (NASH)"
2020-07-30,Alnylam Pharmaceuticals (ALNY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
2020-07-23,A Top Contender in the Race for a NASH Drug Drops Out
2020-07-23,Alnylam to Webcast Conference Call Discussing Second Quarter 2020 Financial Results
2020-07-14,Alnylam (ALNY) Upgraded to Buy: Here's Why
2020-07-13,"Are Investors Undervaluing Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) By 34%?"
2020-07-13,Alnylam Announces that the United Kingdoms MHRA Grants Early Access to Lumasiran
2020-07-09,"Did Hedge Funds Make The Right Call On Alnylam Pharmaceuticals, Inc. (ALNY) ?"
2020-07-08,Alnylam Pharmaceuticals and Taiba Group Partner to Commercialize RNAi Therapeutics in the Gulf States
2020-07-01,Alnylam Pharma Poised to Shoot Higher
2020-07-01,"FOCUS-From Parkinson's to peanut allergy, pandemic puts brakes on new drugs"
2020-06-30,Alnylam Reports New 12-Month Interim Data From the ENVISION Phase 3 Study of Givosiran in Acute Hepatic Porphyria
2020-06-28,New Pharma ETF Focuses on Testing and Treatment for Infectious Diseases--but Not Covid-19
2020-06-18,"Alnylam to Host Seventh Annual ""RNAi Roundtable"" Webcast Series"
2020-06-17,Alnylam to Webcast Presentation at Bank of America Securities 2020 Napa Biopharma Conference
2020-06-17,Alnylam???s Share Price Rises YTD on Pipeline Developments
2020-06-10,Alnylam Announces Publication of ENVISION Phase 3 Study Results for Givosiran in the New England Journal of Medicine
2020-06-08,Alnylam Reports Positive Phase III Results on Lumasarin
2020-06-08,Pfizer Is Charging Ahead With A Coronavirus Vaccine  Is PFE Stock A Buy?
2020-06-08,Alnylam Reveals Solid Lumasiran Results; Analyst Says Dicerna Better Pick
2020-06-07,"Alnylam Presents Positive Phase 3 Results from ILLUMINATE-A Study of Lumasiran, an Investigational RNAi Therapeutic for Treatment of Primary Hyperoxaluria Type 1"
2020-06-05,Why Is Alnylam (ALNY) Down 6.8% Since Last Earnings Report?
2020-06-04,"Alnylam Pharmaceuticals, Inc. (ALNY): Hedge Funds Are Getting Bullish"
2020-06-02,Alnylam Announces Recipients of Second Annual Advocacy for Impact Grants Program
2020-06-01,Alnylam to Webcast Conference Call Discussing Full Results from ILLUMINATE-A Phase 3 Study of Lumasiran at ERA-EDTA International Congress
2020-05-27,Alnylam's (ALNY) Lumasiran NDA Gets Priority Review From FDA
2020-05-26,Alnylam to Webcast Presentations at Upcoming June Investor Conferences
2020-05-26,Edited Transcript of ALNY earnings conference call or presentation 6-May-20 12:30pm GMT
2020-05-26,Alnylam Announces U.S. Food and Drug Administration Has Granted Priority Review of the Lumasiran New Drug Application for the Treatment of Primary Hyperoxaluria Type 1
2020-05-25,Is Alnylam Pharmaceuticals (ALNY) Outperforming Other Medical Stocks This Year?
2020-05-22,Alnylam Presents New Long-Term Results from Global Open-Label Extension Study of ONPATTRO® (patisiran) at the European Academy of Neurology Virtual Congress 2020
